Advertisement
Case Reports| Volume 333, ISSUE 3, P197-199, March 2007

Download started.

Ok

Prosthetic Valve Endocarditis due to Acinetobacter spp: A Rare Case and Literature Review

      ABSTRACT

      A rare case of prosthetic valve endocarditis from Acinetobacter spp occurring 9 months postoperatively is described. The patient initially received empirical therapy against pathogens commonly associated with prosthetic valve endocarditis, but his condition did not improve. Identification of bacteremia due to Acinetobacter spp was not attributed to any of the classic nosocomial factors such as presence of a catheter or a recent invasive procedure. The patient did well with an intravenous regimen of meropenem and tobramycin instituted according to susceptibility testing. Physicians should be aware of this rare association of a nosocomial pathogen such as Acinetobacter spp with prosthetic valve endocarditis occurring long after the initial cardiothoracic procedure.

      KEY INDEXING TERMS

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Van Looveren M.
        • Goossens H.
        Antimicrobial resistance of Acinetobacter spp. in Europe.
        Clin Microbiol Infect. 2004; 10: 684-704
        • Seifert H.
        • Strate A.
        • Pulverer G.
        Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality.
        Medicine (Baltimore). 1995; 74: 340-349
        • Gradon J.D.
        • Chapnick E.K.
        • Lutwick L.I.
        Infective endocarditis of a native valve due to Acinetobacter: case report and review.
        Clin Infect Dis. 1992; 14: 1145-1148
        • Malik A.S.
        Acinetobacter endocarditis in children: a case report and review of the literature.
        Infection. 1995; 23: 306-308
        • Weinberger I.
        • Davidson E.
        • Rotenberg Z.
        • et al.
        Prosthetic valve endocarditis caused by Acinetobacter calcoaceticus subsp. wolffi.
        J Clin Microbiol. 1987; 25: 955-957
        • Bergogne-Berezin E.
        • Towner K.J.
        Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.
        Clin Microbiol Rev. 1996; 9: 148-165
        • Al Khoja M.S.
        • Darrel A.H.
        The skin as the source of Acinetobacter and Moraxella species occurring in blood cultures.
        J Clin Pathol. 1979; 32: 497-499
        • Struelens M.J.
        • Carlier E.
        • Maes N.
        • et al.
        Nosocomial colonization and infection with multiresistant Acinetobacter baumannii: outbreak delineation using DNA macrorestriction analysis and PCR-fingerprinting.
        J Hosp Infect. 1993; 25: 15-32
        • Cisneros J.M.
        • Rodriguez-Bano J.
        Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment.
        Clin Microbiol Infect. 2002; 8: 687-693
        • Badour L.M.
        • Wilson W.R.
        Infections of prosthetic valves and other cardiovascular devices.
        in: Mandell G.L. Bennett J.E. Dolin R. Mandell, Douglas, and Bennett’s Principles and practice of infectious diseases, vol 1.6th ed. Churchill Livingstone, Philadelphia2005: 1024-1044
        • Rivas P.
        • Alonso J.
        • Moya J.
        • et al.
        The impact of hospital-acquired infections on the microbial etiology and prognosis of late-onset prosthetic valve endocarditis.
        Chest. 2005; 128: 764-771
        • Chu Y.W.
        • Leung C.M.
        • Houang E.T.
        • et al.
        Skin carriage of Acinetobacter in Hong Kong.
        J Clin Microbiol. 1999; 37: 2962-2967
        • Seifert H.
        • Dijkshoorn L.
        • Gerner-Smidt P.
        • et al.
        Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods.
        J Clin Microbiol. 1997; 35: 2819-2825
        • Corbella X.
        • Ariza J.
        • Ardanuy C.
        • et al.
        Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii..
        J Antimicrob Chemother. 1998; 42: 793-802
        • Wisplinghoff H.
        • Perbix W.
        • Seifert H.
        Risk factors for nosocomial bloodstream infections due to Acinetobacter baumannii: a case-control study of adult burn patients.
        Clin Infect Dis. 1999; 28: 59-66
        • Mallon P.W.
        • Millar B.C.
        • Moore J.E.
        • et al.
        Molecular identification of Acinetobacter spp. in a patient with culture-negative endocarditis.
        Clin Microbiol Infect. 2000; 6: 277-278
        • Castellanos Martinez E.
        • Telenti Asensio M.
        • Rodriguez Blanco V.M.
        • et al.
        Infective endocarditis of an interventricular patch caused by Acinetobacter haemolyticus..
        Infection. 1995; 23: 243-245
        • Alvarez J.
        • Salas J.
        • Barakat S.
        • et al.
        [Dehiscence of a composite aortic graft (Bono and Bentall technique) secondary to Acinetobacter endocarditis].
        Rev Esp Cardiol. 1998; 51: 769-771
        • Marques M.B.
        • Bookings E.S.
        • Moser S.A.
        • et al.
        Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of 9 antimicrobial combinations.
        Antimicrob Agents Chemother. 1997; 41: 881-885
        • Michalopoulos A.S.
        • Tsiodras S.
        • Rellos K.
        • et al.
        Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.
        Clin Microbiol Infect. 2005; 11: 115-121